Company Filing History:
2 out of 216 
1 out of 1,152 
1 out of 130 
Years Active: 2003-2012
Title: Mark Cornebise: Innovator in Pharmaceutical Inventions
Introduction
Mark Cornebise is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on developing compounds that have therapeutic applications in various medical conditions.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Inhibitors of C-MET and uses thereof." This invention relates to compounds that serve as inhibitors of PI3K, particularly targeting PI3Kγ. The invention also encompasses pharmaceutically acceptable compositions that include these compounds and outlines methods for using them in the treatment of various diseases, conditions, or disorders. Another significant patent is for "Cell adhesion inhibitors," which can interact with VLA-4 molecules to inhibit VLA-4 dependent cell adhesion. Notably, an inhibitor that includes a polyethylene glycol moiety can exhibit advantageous pharmaceutical properties.
Career Highlights
Mark Cornebise has worked with prominent companies in the pharmaceutical industry, including Biogen Idec and Vertex Pharmaceuticals. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Mark has collaborated with talented individuals such as Daniel M. Scott and Wen-Cherng Lee. These collaborations have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Mark Cornebise is a distinguished inventor whose work in pharmaceutical innovations has the potential to impact the treatment of various medical conditions. His patents reflect a commitment to advancing healthcare through scientific discovery.